If an employee uses marijuana off the clock and the employer doesn’t test for marijuana, isn’t it much like the tree falling in the woods?
A recent Wall Street Journal report (“More U.S. Workers Are Testing Positive for Marijuana. Fewer Employers Are Concerned,” July 10, 2026) suggests that is the case, laying out data that
The April order rescheduling DEA-approved medications and state-licensed medical marijuana to Schedule III set off a scramble in the capital markets. Two questions sit at the center of it: Can plant-touching companies finally list on the major U.S. stock exchanges, and will banks finally open their doors to the industry? On the first question, the
President Trump has announced he will nominate Todd Blanche — his former personal attorney, who has been running the Department of Justice in an acting capacity — to serve as permanent attorney general. I wrote back in April about the personnel shuffle that put Blanche in the acting AG chair and what it might mean
It’s déjà vu all over again. In a move that surprised many — and disappointed more — Virginia Gov. Abigail Spanberger has vetoed legislation that would have finally established a regulated adult-use marijuana retail market in the Commonwealth. The veto is notable not just for what it means for Virginia consumers and operators, but for
In the summer of 2017, Phish lit up Madison Square Garden with a historic 13-night run. Your friends at Budding Trends believe the marijuana rescheduling decision calls for a rollout just as monumental, so we’ve created the Budding Trends Baker’s Dozen as a fitting homage.
Following the federal government’s move to reschedule medical marijuana from
One of the questions I have been asked most often since the Acting Attorney General Todd Blanche signed a final order moving FDA-approved marijuana products and state-licensed medical marijuana from Schedule I to Schedule III of the Controlled Substances Act is whether the federal government’s decision to move state-licensed medical marijuana to Schedule III will
Dr. Marty Makary resigned as FDA commissioner last week, barely a year after his Senate confirmation. HHS Secretary Robert F. Kennedy Jr. confirmed the departure and indicated the agency is searching for a replacement. Kyle Diamantas, FDA’s deputy commissioner for Food, will serve as acting commissioner in the meantime. The vacancy arrives at an extraordinarily
This is the tenth of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.
There were massive cheers in the
This is the fourth of 13 posts describing the impacts of marijuana’s rescheduling. An homage to Phish’s historic run at Madison Square Garden in the Summer of 2017, Budding Trends Baker’s Dozen will address how rescheduling affects various areas of the law and our daily lives. Enjoy the run.
Rescheduling marijuana to Schedule III is
Here at Budding Trends, we like to roll up our “Top 10 Weed Roundup” between the sacred and renowned 420 holidays. Each year, we pack a recap post with 10 highly read blog posts since the previous 420 to see what’s shakin’ on shakedown street over the last year — and we have seen